|
WO2020223762A1
|
|
Methods for treating muscular dystrophy using inhibitory oligonucleotides to cd49d
|
|
EP3787639A1
|
|
Therapeutic uses and methods
|
|
EP3638253A1
|
|
Methods for treating multiple sclerosis using antisense oligonucleotides
|
|
US2015344890A1
|
|
Modulation of Insulin Like Growth Factor I Receptor Expression in Cancer
|
|
EP3007704A1
|
|
Combination therapy for acromegaly
|
|
NZ629004A
|
|
Combination therapy comprising a growth hormone variant and an oligonucleotide targeted to the growth hormone receptor
|
|
AU2011301712A1
|
|
Method for reducing the number of certain circulating leukocytes in a human subject
|
|
AU2005327506A1
|
|
Antisense modulation of integrin alpha4 expression
|
|
CA2515484A1
|
|
Modulation of insulin like growth factor i receptor expression
|
|
AU2003902610A0
|
|
Modulation of insulin like growth factor i receptor expression - ii
|
|
AU2003900609A0
|
|
Modulation of insulin like growth factor i receptor expression
|
